Nicola Lawrence — ASN Events

Nicola Lawrence — ASN Events

Nicola Lawrence

NHMRC CTC, NSW, Australia

Nicola Lawrence is a Medical Oncologist who trained in New Zealand before moving to Sydney in early 2015 to pursue research opportunities. I am currently working as an ANZUP research fellow and am undertaking a PhD at the University of Sydney in optimising clinical trials in the era of molecularly targeted treatments and immune therapies. I have an interest in clinical trial methodology and genito-urinary cancers.

Presentations this author is a contributor to:

A randomised phase 3 trial of accelerated versus standard BEP chemotherapy for patients with intermediate and poor-risk metastatic germ cell tumours: The P3BEP Trial (ANZUP 1302) (#266)

Randomised phase 3 double-blind placebo-controlled trial of methoxyflurane with periprostatic local anaesthesia to reduce the discomfort of transrectal ultrasound-guided prostate biopsy (Pain-Free TRUS B): ANZUP 1501 (#270)

Randomised phase 3 trial of the addition of Mitomycin to BCG as adjuvant intravesical therapy for high-risk, non-muscle-invasive bladder cancer(ANZUP 1301) (#267)